While non-biological factors play an important role in OC health disparity, there is evidence to suggest a critical role of biological factors in OC health disparity as well [
6]. In fact, enhanced incidence and mortality in AA women with OC has been observed, as compared to EA counterparts, even when socioeconomic factors have been accounted for. For example, in a study that evaluated 393 OC patients (68 AA vs. 325 CA), a clear survival disadvantage was observed in AA patients [
21]. The AA patients had lower SES, in terms of education, income and property, to start with. However, the survival disadvantage was evident even when controlled for these factors. Progression free survival was only 16 months in AA OC patients, as compared to 27 months in CA OC patients, whereas overall survival was less than half in AA patients (42 months), as compared to CA patients (88 months). Possible involvement of biological factors in OC health disparity was also suggested in a study that factored for access to healthcare, and still observed poor survival of AA OC patients, compared to CA patients [
10].
Higher adiposity is a known OC risk [
27]. Since AA women have disproportionately high rate of obesity [
28], a study was carried out to evaluate whether body mass index (BMI) or the weight gain since the age of 18 years can be independent OC risk factors [
27]. It was observed that a BMI ≥ 40 posed a significant OC risk, compared to BMI < 25, thus connecting obesity with increased OC risk. Similarly, gain of weight since age 18 also correlated positively with OC risk [
27]. In a similar study, where BMI ≥ 30 was considered obese, AA women with higher BMI reported having OC symptoms much before the formal diagnosis [
29]. Severe obesity is a critical risk factor for OC [
30], underlining the importance of healthy and active lifestyle.
Genetic factors associated with ovarian cancer health disparities
The underlying causes for OC health disparities are complex; they are clearly a mixture of biological as well as non-biological factors [
31]. Phosphoserine phosphatase like (PSPHL) expression is elevated in AAs, compared to CAs [
32]. PSPHL was primarily identified as a differentially over-expressed gene in AA endometrial cancers, relative to CA endometrial cancers. Since both ovarian and endometrial cancers belong to the family of gynecological cancers, the study was extended to evaluate PSPHL expression in AA vs. CA OCs as well. Similar to endometrial cancers, PSPHL was found to be elevated in AA OCs, as compared to CA OCs. Interestingly, PSPHL levels are relatively higher in AA breast tumors than the CA breast tumors [
33]. Health disparities in breast cancer are well documented [
34,
35] and the study on PSPHL in breast tumors [
33] identified partial deletion (30Kb long fragment) of chromosome 7p11 in CA women, which led to attenuation of expression of PSPHL in CA breast tumors. No such mechanism was proposed for observed disparate expression of PSPHL in OCs of AA vs. CA origin, and would be interesting to elucidate.
AA women are at relatively higher risk of OC because of higher rates of BRCA1 and BRCA2 mutations, as compared to other racial/ethnic populations [
36,
37]. This represents an interesting evolution in our understanding of BRCA mutations in AA women because early studies on the subject seemed to suggest the opposite; that AA women harbor significantly less BRCA mutations, compared to CA women [
3]. BRCA1 and BRCA2 are tumor suppressors that play a role in repair of damaged DNA. Inherited mutations in BRCA1 and BRCA2 often result in breast and/or OC. It has been estimated that the patients with BRCA1 mutations have 39% while those with BRCA2 mutations have 11% risk of developing OC by an age of 70 years [
38].
The connection between inflammation and cancer is well known [
39], and, recently, it has been suggested that pro-inflammatory diet leads to increased risk of epithelial OC in AA women [
40]. The study calculated ‘dietary inflammatory index’ through a questionnaire that focused on dietary intake in the year prior to diagnosis of OC [
40]. Women that consumed the most pro-inflammatory diet were at significantly higher risk of epithelial OC. Inflammation is known to play a role in OC onset and progression [
41]. The pro-inflammatory cytokines produced within the tumor microenvironment help ovarian tumors proliferate as well as evade chemotherapy [
42]. Studies document that high intake of carbohydrate-rich foods may result in the production of IGF-1 that is known to promote ovarian tumorigenesis via stimulation of hormones such as androgens. Moreover, alterations in glucose levels could induce oxidative DNA damage [
16]. Analgesic medications also seem to play a role in OC risk. AA women taking aspirin for prevention of cardiovascular diseases or the non-aspirin nonsteroidal anti-inflammatory drugs for arthritis had 44% and 26% lower risk of epithelial OC, respectively [
43].
Vitamin D is another factor that is increasingly being correlated with cancer health disparities [
44]. The darker skin pigmentation in AA populations results in significantly lower serum vitamin D levels, and since vitamin D levels inversely correlate with multiple cancers [
44], lower serum vitamin D levels are observed in patients diagnosed with different cancers, including OC. It has been suggested that daily intake of vitamin D, along with calcium, can reduce the cancer risk in women by 60% [
45]. Further, for every 10 ng/mL increase in the levels of vitamin D, the cancer risk decreases by 35% [
45]. As a direct connection between OC and vitamin D, it has been reported that OC patients are four times more likely to have lower serum vitamin D levels, as compared to healthy controls [
46]. Studies have shown that vitamin D inhibits cancer cell proliferation by inducing cell cycle arrest at G1 phase via up-regulation of expression of CDKIs p21WAF 1/ Cip 1 and p27Kip [
47]. A vitamin D response element is also known to be present in the promoter region of p21 gene, suggesting that vitamin D may directly cause the transcriptional activation of p21 [
48].
Gene polymorphisms have also been implicated in disparate OC in AA women. Vitamin D receptor polymorphism, particularly at a minor allele rs7975232, has been linked to higher risk of epithelial OC in AA women [
49]. SNP rs7305032, in close proximity to this allele, correlated with nearly two-folds increased risk of invasive epithelial OC in AA women [
49]. Similarly, CAG repeat length polymorphism in exon 1 of androgen receptor gene was observed to increase risk of OC in AA, with, interestingly, no such correlation in CA [
50]. In one of the earliest studies on the topic, racially disparate polymorphism of tumor suppressor gene p53 was suggested [
51]. Codon 72 of p53 gene has arginine and proline allelotypes. The arginine allelotype is more frequent in CAs while the proline allelotype is more frequent in AAs [
51]. In a study that evaluated the 6A allele of type I transforming growth factor beta receptor 1 (TGFβR1), no increased OC risk was associated with the allele [
52]. However, significant racial differences in the frequency of this allele were observed, with the allele being relatively infrequent in AA women (2.4%), compared to CA women (10.7%). A more thorough study would be needed to better understand the link between this TGFβR1 allele and racial disparity in OC.
Epigenetic changes in ovarian cancer health disparities
Epigenetic changes are known to function as liaisons between socioeconomic factors and the genome; they keep accumulating and affecting the epigenome in various racial/ethnic groups, resulting in disparate and poor cancer outcomes [
35]. A functional role of epigenetic changes in aggressive high-grade serous OC has been described, leading to resistance against platinum-containing chemotherapy [
53]. AA OCs are much more aggressive, and associated with poor overall survival, compared to CA OCs. This suggests the possibility of epigenetic modifications as factors that play a role in OC health disparity, an idea that has not yet been tested.
As mentioned above, endometrial cancers and OCs belong to the same family of gynecological cancers. Incidentally, there is evidence in the literature suggesting an epigenetic basis of health disparity in endometrial cancers [
35], particularly, differential ribosomal DNA methylation in AA vs. CA patients [
54]. This raises the hope that the differential methylation, as observed in drug-resistant OCs [
53] might also be relevant in OC health disparity. This speculation is further fueled by some indirect evidences that link epigenetically-regulated genes in OC with health disparities in other cancers. For example, methylation of
TUSC3 (tumor suppressor candidate 3) [
55] has been linked to poor disease-free survival of OC patients.
TUSC3 was part of a gene signature evaluated for differential methylation and expression in AA vs. non-CA breast tumors [
56]. Further, silencing of
SPARC, through hypermethylation, has been reported in OC [
57]. This gene was part of a signature that was investigated for putative role in prostate cancer health disparity. SPARC has been reported to be frequently down-regulated in cancer cells [
58]. It is silenced through promoter methylation in metastatic and aggressive cancer cells [
59]. Finally,
BCAT1 (branched chain amino-acid transaminase 1) is reportedly over-expressed in ovarian tumors [
60], possibly through a mechanism involving hypomethylation [
61].
BCAT1 was one of the top up-regulated genes in AA colorectal cancer patients-derived samples, as compared to samples from CA colorectal cancer patients. In light of these observations, it might be worthwhile to evaluate these genes, as a starting point, for their potential disparate expression and a role in OC health disparity.
Regulation of gene expression by differential methylation is a classic example of epigenetic event. However, regulation of genes through miRNAs is also within the broader definition of epigenetic changes. A number of miRNAs have been reported deregulated in OC models with potential role as diagnostic and/or prognostic markers [
62]. Also, miR-152 has been shown to regulate DNMT1 (DNA methyltransferase-1) [
63], an enzyme that actively influences the overall methylation status by transferring methyl groups to its targets. miR-152 is also linked to cancer health disparity as it was significantly down-regulated in about ~50% of AA prostate cancer tissues, compared to 35% of CA samples [
64].
Interplay of genetic and environmental factors in ovarian cancer and associated health disparities
Environmental factors influence genetic factors, and such interactions lead to onset of human cancers. Risk of OC has been linked to several environmental factors [
65,
66]. Although occupational exposures and environmental factors seem to correlate with increased OC risk, epidemiological analyses have often failed to establish a positive link [
67,
68]. This has been blamed on cohort size, statistical power and several other factors.
One environmental factor that has been linked to increased OC risk is the use of pesticides and herbicides [
66]. This is particularly concerning in developing countries where stable organochlorine pesticides represent a bulk of pesticides in use [
69]. These pesticides persist in environmental because they are not easily biodegradable and the half-lives run in decades. Their carcinogenic activity is related to estrogen-mimicking property [
69]. While indiscriminate use of such harmful compounds is relatively more prevalent in under-developed and developing countries, even the developed countries are not immune to this environmental risk of OC. For example, in the US, pesticide atrazine has been detected in public water supplies in Iowa [
70]. It is documented that atrazine causes phosphorylation of ERK and induces expression of oncogenes such as cyclin A, progesterone receptors, c-fos etc. to promote the proliferation of cancer cells [
71]. Levels of nitrates in the drinking water were linked to an increase in OC risk, especially among the post-menopausal women, in the Iowa Health Women’s study [
72]. CYP2E1 gene mutation is reported to be associated with cytotoxicity and DNA damage as a result of nitrosamines [
73]. Based on this, it could be speculated that there may be an association between high nitrate containing drinking water and genetic variation in CYP2E1, which may present increased risk of OC in AA women.
Talc, consisting of magnesium silicate, is another environmental factor with possible carcinogenic implications. The association between talc (talcum) and OC has been controversial, and a subject of legal battles [
74]. When applied to genital areas, diaphragms or sanitary napkins, it can possibly cause OC. A pooled analysis of 8525 patients observed a moderate risk of OC in patients with reported genital powder use [
75], with positive correlation between powder use and elevated risk of individual OC subtypes. A prospective study that followed 61,576 post-menopausal women for 12.4 years, however, could not link talc use with OC risk [
76]. The results were confirmed by another independent study which found douching, and not talc use, as a risk factor for OC [
77]. A recent meta-analysis, however, confirmed risk of OC from genital talc use with a statistically significant risk of serous OC [
78]. It has been suggested that the risk of OC from genital talc use is rather complex, and involves many considerations, such as menopause status, hormone therapy, weight, smoking etc. [
79]. Harmful effects of talc include elevated immunoglobulins and heat shock proteins [
80]. In a gene-talc interactions study performed in OC, it was observed that women exhibiting specific genetic polymorphism in
GSTM1 and
GSTT1 may have a higher risk of serous invasive OC, associated with genital talc use [
81]. Functional role of
GSTM1 and
GSTT1 in the metabolism of carcinogens and reactive oxygen species has been reported [
82]. Thus, although, environmental factors have been suggested to influence OC, and even confirmed by a few analyses, the topic remains controversial with individual analyses marked by limitations that prevent an objective assessment and a definite conclusion. While designing future studies, it would also be interesting to evaluate the role of several environmental risk factors in OC cancer health disparities.